Literature DB >> 10102973

Depletion of colonic detoxication enzyme activity in mice with dextran sulphate sodium-induced colitis.

M L Clapper1, R H Adrian, G R Pfeiffer, K Kido, L Everley, H S Cooper, S Murthy.   

Abstract

BACKGROUND: The increased risk of colonic malignancies in individuals with ulcerative colitis has prompted a search for early biomarkers of disease progression. AIM: To characterize Phase II detoxication enzyme expression during acute and chronic colitis. The mouse model of dextran sulphate sodium (DSS)-induced colitis represents a relevant system with which to sequentially evaluate the spectrum of biochemical changes associated with colorectal cancer risk.
METHODS: Acute and chronic colitis were induced in Swiss Webster mice by administering DSS in the drinking water (5%) for 1-4 cycles. Each cycle consisted of 7 days DSS and 14 days of water. The glutathione S-transferase (GST) activity, gamma-glutamylcysteine synthetase (gamma-GCS) activity and glutathione content of the colonic tissues were determined at various time points throughout the experiment. Alterations in GST isozyme expression were confirmed by Western and Northern blot.
RESULTS: GST activity was reduced significantly in the colon by the end of Cycle 1 (84% of control values). Specific activities continued to decrease with subsequent cycles of DSS exposure. By the end of Cycle 4, glutathione levels and gamma-GCS activity had reached 29% and 56% of control, respectively.
CONCLUSIONS: These data suggest that detoxication enzyme depletion is associated with both acute and chronic colitis and may be an important event in the progression of ulcerative colitis to colon cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102973     DOI: 10.1046/j.1365-2036.1999.00475.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats.

Authors:  Valentina Vasina; Massimiliano Broccoli; Maria Grazia Ursino; Donatella Canistro; Luca Valgimigli; Antonio Soleti; Moreno Paolini; Fabrizio De Ponti
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

2.  Thiol methyltransferase activity in inflammatory bowel disease.

Authors:  W E Roediger; W J Babidge
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

3.  Experimental colitis and malnutrition differentially affect the metabolism of glutathione and related sulfhydryl metabolites in different tissues.

Authors:  Photios Vassilyadi; Scott V Harding; Evan Nitschmann; Linda J Wykes
Journal:  Eur J Nutr       Date:  2015-07-25       Impact factor: 5.614

4.  A novel mouse model for colitis-associated colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sulfate sodium.

Authors:  Jian-Guo Wang; Dong-Fei Wang; Bing-Jian Lv; Jian-Min Si
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

5.  Selective expression of detoxifying glutathione transferases in mouse colon: effect of experimental colitis and the presence of bacteria.

Authors:  Maryam Edalat; Bengt Mannervik; Lars-Göran Axelsson
Journal:  Histochem Cell Biol       Date:  2004-08       Impact factor: 4.304

6.  BTZO-15, an ARE-activator, ameliorates DSS- and TNBS-induced colitis in rats.

Authors:  Hiroshi Yukitake; Haruhide Kimura; Hirobumi Suzuki; Yasukazu Tajima; Yoshimi Sato; Toshihiro Imaeda; Masahiro Kajino; Masayuki Takizawa
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.